Suppose one of the drugs under investigation for COVID-19 effectively reduces its morbidity and mortality. For simplicity let’s say that it quickly and completely cures 90% (or X%) of patients but does nothing to the remaining 10%, and we manage to scale up manufacturing enough to be able to treat everyone with the drug. Would the major developed countries then decide to relax the current mitigation/suppression policies and let the pandemic run its course (thereby accepting the morbidity/mortality of the refractory 10%) in order to revive their economies? What do you think the threshold for X would be for the major developed countries to do this?
I feel like there’s wet spaghetti code at both ends of this? On one side we have economic impact projections that vary about an order of magnitude and the other we have expected death projections that vary over 1-2 orders of magnitude.
Suppose one of the drugs under investigation for COVID-19 effectively reduces its morbidity and mortality. For simplicity let’s say that it quickly and completely cures 90% (or X%) of patients but does nothing to the remaining 10%, and we manage to scale up manufacturing enough to be able to treat everyone with the drug. Would the major developed countries then decide to relax the current mitigation/suppression policies and let the pandemic run its course (thereby accepting the morbidity/mortality of the refractory 10%) in order to revive their economies? What do you think the threshold for X would be for the major developed countries to do this?
I feel like there’s wet spaghetti code at both ends of this? On one side we have economic impact projections that vary about an order of magnitude and the other we have expected death projections that vary over 1-2 orders of magnitude.